Mindful or mind full? An eight week program for people with multiple sclerosis
Type of Study/Intervention
Randomised controlled trial with follow-up observations (a pilot study)
Form of MS
RRMS, PPMS, SPMS
Many people with multiple sclerosis (MS) experience stress, anxiety and/or depression. Mindfulness and yoga programs have promising potential for managing the mental health of people with MS, but knowledge about the benefits of these programs for people with MS is limited.
The aims of this study are to: 1) test effects of different online mindfulness programs on mental health, pain, number of visits to health professionals, and quality of life scores in participants from baseline and immediately at the conclusion of the eight-week program, and every four weeks thereafter over a six-month follow-up; 2) explore acceptability of the program, 3) understand the reasons that motivate or prevent participants from practising mindfulness.
This study will contribute new knowledge about what people with MS think of mindfulness programs, and their impact on ongoing mental health, pain and quality of life for people with MS. This will not only inform the development of a larger multi-centre randomised controlled trial but is likely to improve the delivery of support services to people with MS, including those who live in remote areas.
A total of 75 adults will be taking part in this pilot project.
Inclusion criteria will be people who are aged ≥18 years, with a diagnosis of MS, able to speak and understand English, have internet access and an electronic device that they can use to watch videos and to video call (e.g. Skype) and able to commit to the eight-week program that involves a weekly 1 hour online meeting and 15-20mins of daily home practice, starting in May/June and follow-up up to six months.
Participants will be excluded if they are judged to potentially require individual psychological treatment. Participants falling in the high-risk category on a scale of psychological distress will be encouraged to seek individual treatment instead.
Anticipated start date
Recruitment will start on 1st April 2019 with the intervention to begin in May/June 2019.
Full details of the trial can be found on the ANZCTR clinical trials database
NSW/SA/VIC/QLD/WA/TAS (everywhere in Australia)